Chinese FinTech CFO on IPO Day: Mobile, Blockchain Will Drive Industry Innovation
FinTech in China is booming, and one of the country's peer-to-peer lenders is making its market debut on the New York Stock Exchange. Simon Ho, CFO of PPDAI, joins us to discuss his company's decision to go public. Shares opened for trading at $13.30, slightly above its IPO price of $13 a share.
PPDAI is not the only Chinese lending company seeking investments from the public markets. Ho fills Cheddar in on why there is such a massive opportunity in peer-to-peer lending in China. He notes that companies capitalized on the governments unwillingness to hand out small loans to individuals.
The IPO comes during a time of heightened concerns over Chinese regulations over tech companies. Regulators are worried some lenders are charging unreasonably high rates. Ho explains how the PPDAI is navigating the waters of regulations and breaks down the company's rate structure.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
